Skip to main content

and
  1. Article

    Open Access

    The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer

    The alternative splicing of PML precursor mRNA gives rise to various PML isoforms, yet their expression profile in breast cancer cells remains uncharted. We discovered that PML1 is the most abundant isoform in al...

    Chun-Peng Pai, Han Wang, Darcie D. Seachrist, Neel Agarwal in Cell Death & Differentiation (2024)

  2. Article

    Open Access

    Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers

    We recently established c-Abl as a potent suppressor of triple-negative breast cancer (TNBC) progression through its reactivation of a p53:p21 signaling axis coupled to senescence. Moreover, we observed co-exp...

    Chevaun D Morrison, Jenny C Chang, Ruth A Keri, William P Schiemann in Cell Death & Disease (2017)

  3. No Access

    Article

    Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-β signaling in ErbB2/Neu-induced tumors from transgenic mice

    Upregulation of HER2/ErbB2/Neu occurs in 15–30% of human breast cancers and correlates with poor prognosis. Identification of ErbB2/Neu transcriptional targets should facilitate development of novel therapeuti...

    Melissa D Landis, Darcie D Seachrist, Marjorie E Montañez-Wiscovich in Oncogene (2005)

  4. No Access

    Article

    High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-α-subunit promoter/Simian virus 40 T-antigen fusion gene

    Transgenic (TG) mice expressing the Simian virus 40 T-antigen under the control of the murine inhibin-α promoter (Inhα/Tag) develop granulosa and Leydig cell tumors at the age of 5–6 months, with 100% penetrance....

    Maarit Mikola, Jukka Kero, John H Nilson, Ruth A Keri, Matti Poutanen in Oncogene (2003)